Fractyl Health, Inc. (GUTS) — 10-Q Filings
All 10-Q filings from Fractyl Health, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Fractyl Health's Q3 Net Loss Widens to $45.6M Amid R&D Spend
— Nov 12, 2025 Risk: high
Fractyl Health, Inc. (GUTS) reported a significant net loss of $45.603 million for the three months ended September 30, 2025, a substantial increase from the $2 -
Fractyl Health Burns Cash, Raises Capital Amidst Clinical Trials
— Aug 12, 2025 Risk: high
FRACTYL HEALTH, INC. (GUTS) reported no revenue for the three and six months ended June 30, 2025, consistent with the prior year periods, as the company remains -
Fractyl Health Files Q1 2025 10-Q
— May 13, 2025 Risk: medium
Fractyl Health, Inc. filed its quarterly report on Form 10-Q for the period ending March 31, 2025. The company's principal executive offices are located at 3 Va -
Fractyl Health Files Q3 2024 10-Q
— Nov 12, 2024 Risk: medium
Fractyl Health, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported financial results and operational updates. Key financial data -
Fractyl Health Files Q2 2024 10-Q
— Aug 14, 2024 Risk: medium
Fractyl Health, Inc. filed its 10-Q for the period ending June 30, 2024. The company, located at 3 Van De Graaff Drive, Burlington, MA, is involved in the Surgi -
Fractyl Health, Inc. Files 10-Q for Period Ending March 31, 2024
— May 13, 2024 Risk: low
FRACTYL HEALTH, INC. (GUTS) filed a Quarterly Report (10-Q) with the SEC on May 13, 2024. Fractyl Health, Inc. filed a 10-Q report for the period ending March 3
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX